Published in Laryngoscope on November 01, 2004
Use of cidofovir in HPV patients with recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2014) 1.61
Human papillomavirus type 6 and 11 genetic variants found in 71 oral and anogenital epithelial samples from Australia. PLoS One (2013) 1.45
Recurrent respiratory papillomatosis: an overview of current thinking and treatment. Eur Arch Otorhinolaryngol (2007) 1.08
Recurrent respiratory papillomatosis: a complex defect in immune responsiveness to human papillomavirus-6 and -11. APMIS (2010) 1.03
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol (2006) 0.94
Recurrent respiratory papillomatosis: a rare chronic disease, difficult to treat, with potential to lung cancer transformation: apropos of two cases and a brief literature review. Case Rep Oncol (2011) 0.91
Experience with recurrent respiratory papillomatosis in a developing country: impact of tracheostomy. World J Surg (2013) 0.91
Recurrent respiratory papillomatosis: HPV genotypes and risk of high-grade laryngeal neoplasia. PLoS One (2014) 0.89
Recurrent respiratory papillomatosis: current and future perspectives. Ther Clin Risk Manag (2015) 0.89
Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2014) 0.82
Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients. Eur Arch Otorhinolaryngol (2013) 0.81
Age of child, more than HPV type, is associated with clinical course in recurrent respiratory papillomatosis. PLoS One (2008) 0.81
Recurrent respiratory papillomatosis. Arch Dis Child (2006) 0.79
Genomic differences in the background of different severity in juvenile-onset respiratory papillomatoses associated with human papillomavirus type 11. Med Microbiol Immunol (2013) 0.78
Pharyngeal squamous cell papilloma in adult Japanese: comparison with laryngeal papilloma in clinical manifestations and HPV infection. Eur Arch Otorhinolaryngol (2012) 0.77
Global Genomic Diversity of Human Papillomavirus 11 Based on 433 Isolates and 78 Complete Genome Sequences. J Virol (2016) 0.77
Human papillomavirus vaccine policies among american Indian tribes in Washington State. J Pediatr Adolesc Gynecol (2012) 0.76
Risk factors for aggressive recurrent respiratory papillomatosis in adults and juveniles. PLoS One (2014) 0.76
Novel human papilloma virus (HPV) genotypes in children with recurrent respiratory papillomatosis. Eur J Pediatr (2010) 0.76
The impact of cidofovir treatment on viral loads in adult recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2012) 0.75
Recurrent respiratory papillomatosis: the Korle-Bu experience. Ghana Med J (2012) 0.75
Fundamental approaches in molecular biology for communication sciences and disorders. J Speech Lang Hear Res (2012) 0.75
Immunological response to quadrivalent HPV vaccine in treatment of recurrent respiratory papillomatosis. Eur Arch Otorhinolaryngol (2016) 0.75
In situ hybridization signal patterns in recurrent laryngeal squamous papillomas indicate that HPV integration occurs at an early stage. Head Neck Pathol (2011) 0.75
Classification of papillomaviruses. Virology (2004) 14.16
Plasma F2-isoprostanes and coronary artery calcification: the CARDIA Study. Clin Chem (2004) 2.40
Robust production and passaging of infectious HPV in squamous epithelium of primary human keratinocytes. Genes Dev (2009) 1.97
The natural history of human papillomavirus infections of the mucosal epithelia. APMIS (2010) 1.61
Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA (2009) 1.60
Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol (2004) 1.56
Response-guided telaprevir therapy in prior relapsers? The role of bridging data from treatment-naïve and experienced subjects. Hepatology (2012) 1.43
Diabetic nephropathy is accelerated by farnesoid X receptor deficiency and inhibited by farnesoid X receptor activation in a type 1 diabetes model. Diabetes (2010) 1.29
Human papillomavirus (HPV) origin-binding protein associates with mitotic spindles to enable viral DNA partitioning. Proc Natl Acad Sci U S A (2004) 1.22
The farnesoid X receptor modulates renal lipid metabolism and diet-induced renal inflammation, fibrosis, and proteinuria. Am J Physiol Renal Physiol (2009) 1.16
Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system. J Virol (2004) 1.16
Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1 DNA helicase. J Virol (2004) 1.15
Therapy of human papillomavirus-related disease. Vaccine (2012) 1.11
Human papillomavirus (HPV) E7 induces prolonged G2 following S phase reentry in differentiated human keratinocytes. J Biol Chem (2011) 1.11
Casein kinase II motif-dependent phosphorylation of human papillomavirus E7 protein promotes p130 degradation and S-phase induction in differentiated human keratinocytes. J Virol (2008) 1.09
Chaperone proteins abrogate inhibition of the human papillomavirus (HPV) E1 replicative helicase by the HPV E2 protein. Mol Cell Biol (2002) 1.07
Human papillomavirus and cancer prevention: gaps in knowledge and prospects for research, policy, and advocacy. Vaccine (2012) 1.06
Dynamic localization of the human papillomavirus type 11 origin binding protein E2 through mitosis while in association with the spindle apparatus. J Virol (2006) 1.04
Comprehensive control of human papillomavirus infections and related diseases. Vaccine (2013) 1.02
Mitogen-activated protein kinases activate the nuclear localization sequence of human papillomavirus type 11 E1 DNA helicase to promote efficient nuclear import. J Virol (2007) 1.01
Alternative fates of keratinocytes transduced by human papillomavirus type 18 E7 during squamous differentiation. J Virol (2002) 0.99
PIK3CA-mediated PI3-kinase signalling is essential for HPV-induced transformation in vitro. Mol Cancer (2011) 0.98
Retrovirus-mediated gene transfer to analyze HPV gene regulation and protein functions in organotypic "raft" cultures. Methods Mol Med (2005) 0.95
Effect of adenoviral mediated overexpression of fibromodulin on human dermal fibroblasts and scar formation in full-thickness incisional wounds. J Mol Med (Berl) (2007) 0.95
mRNA splicing regulates human papillomavirus type 11 E1 protein production and DNA replication. J Virol (2003) 0.95
Microdebrider versus CO2 laser removal of recurrent respiratory papillomas: a prospective analysis. Laryngoscope (2003) 0.94
Conditionally activated E7 proteins of high-risk and low-risk human papillomaviruses induce S phase in postmitotic, differentiated human keratinocytes. J Virol (2006) 0.94
Analyses of melanoma-targeted oncolytic adenoviruses with tyrosinase enhancer/promoter-driven E1A, E4, or both in submerged cells and organotypic cultures. Mol Cancer Ther (2004) 0.92
A highly efficient system to produce infectious human papillomavirus: Elucidation of natural virus-host interactions. Cell Cycle (2009) 0.92
HPV-18 confers resistance to TNF-alpha in organotypic cultures of human keratinocytes. Virology (2004) 0.91
Immune responses to human papillomavirus in genital tract of women with cervical cancer. Gynecol Oncol (2005) 0.89
The promoter of the human proliferating cell nuclear antigen gene is not sufficient for cell cycle-dependent regulation in organotypic cultures of keratinocytes. J Biol Chem (2002) 0.88
Simultaneous in situ detection of RNA, DNA, and protein using tyramide-coupled immunofluorescence. Methods Mol Biol (2005) 0.86
HPV-18 E6 mutants reveal p53 modulation of viral DNA amplification in organotypic cultures. Proc Natl Acad Sci U S A (2013) 0.85
Remodeling of the human papillomavirus type 11 replication origin into discrete nucleoprotein particles and looped structures by the E2 protein. J Mol Biol (2007) 0.85
Significance and possible causes of false-negative results of reflex human Papillomavirus infection testing. Cancer (2007) 0.81
Strategies to enhance transductional efficiency of adenoviral-based gene transfer to primary human fibroblasts and keratinocytes as a platform in dermal wounds. Wound Repair Regen (2006) 0.80
Human papillomavirus infections: warts or cancer? Cold Spring Harb Perspect Biol (2013) 0.78
Cancer Health Empowerment for Living without Pain (Ca-HELP): study design and rationale for a tailored education and coaching intervention to enhance care of cancer-related pain. BMC Cancer (2009) 0.78
Nonconserved lysine residues attenuate the biological function of the low-risk human papillomavirus E7 protein. J Virol (2011) 0.77
Anal-rectal cytology: correlation with human papillomavirus status and biopsy diagnoses in a population of HIV-positive patients. J Low Genit Tract Dis (2010) 0.77
Robust HPV-18 production in organotypic cultures of primary human keratinocytes. Methods Mol Biol (2015) 0.76
Activation of adenovirus early promoters and lytic phase in differentiated strata of organotypic cultures of human keratinocytes. J Virol (2003) 0.76
Analysis of HPV DNA replication using transient transfection and cell-free assays. Methods Mol Med (2005) 0.76
Magnet supporting patient safety. J Nurs Adm (2014) 0.75